Published on 25 Sep 2021 on TheStreet.com
In a week dominated by fears of a Chinese property company collapse, biotechs fared better than might have been expected. Axsome Therapeutics (AXSM) -...
Start tracking your investments with Statfolio
Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel th...
In this article, we will be taking a look at the 30 countries with the lowest depression rates. I...
Axsome Therapeutics AXSM announced encouraging data from the phase III SYMPHONY study on its inve...
In this article, we will take a look at the top 20 cloudiest cities in the U.S., Ranked. If you w...
Monday, Axsome Therapeutics Inc AXSM released data from the SYMPHONY Phase 3 trial of AXS-12 (reb...
Axsome Therapeutics, Inc. (NASDAQ:AXSM), a company focused on developing therapies for central...
Axsome Therapeutics, Inc. (NASDAQ: NASDAQ:AXSM), a biopharmaceutical company, announced today...
Axsome Therapeutics Inc. (NASDAQ:AXSM) is a fast-growing pharmaceutical company headquartered in ...
It was a busy week for the biotech sector with lots of study data readouts and regulatory approva...
Axsome Therapeutics, Inc. AXSM announced that it has dosed the first patient in the phase III PAR...